荃信生物-B(02509)完成配售500万股

Core Viewpoint - The company, TruMed Health Innovation Fund LP, has successfully completed a placement agreement with a total of 5 million shares at a price of HKD 20.0 per share, representing approximately 2.25% of the issued shares prior to the placement and about 2.20% after the placement [1] Group 1 - The placement agreement conditions have been fulfilled, and the placement is set to be implemented on August 25, 2025 [1] - The placement agent has successfully allocated the shares to the designated subscriber [1]